Literature DB >> 12024907

Prevalence of hepatitis B and hepatitis C virus coinfection in chronic liver disease.

A Xess1, M Kumar, S Minz, H P Sharma, S K Shahi.   

Abstract

Coinfection with HBV and HCV may lead to serious consequences. The present study was done to find out the prevalence of coinfection in patients with chronic liver disease. From patients with hepatitis and chronic liver disease 1673 samples were received and analysed for HBsAg by ELISA. 1342 samples were analysed for anti HCV by third generation ELISA. 493 samples positive for HBsAg were also analysed for Anti HCV to see the prevalence of coinfection. 15(3.0%) were found positive for both HBsAg and anti HCV. Out of 15 patients with coinfection 4 (26.6%) had HCC. Prevalence of HCC in patients with coinfection was higher than either infection alone i.e. HBV-9.1% and HCV-16.5%.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 12024907

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN： 0377-4929            Impact factor:   0.740


  8 in total

Review 1.  Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015.

Authors:  Pankaj Puri; Anil C Anand; Vivek A Saraswat; Subrat K Acharya; Radha K Dhiman; Shiv K Sarin; Shivaram P Singh; Yogesh K Chawla; Rakesh Aggarwal; Deepak Amarapurkar; Anil Arora; Vinod K Dixit; Ajit Sood; Samir Shah; Ajay Duseja; Dharmesh Kapoor; Kaushal Madan; Gaurav Pande; Aabha Nagral; Premashis Kar; Abraham Koshy; Amarender S Puri; C E Eapen; Sandeep Thareja
Journal:  J Clin Exp Hepatol       Date:  2015-09-21

Review 2.  Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.

Authors:  Jacinta A Holmes; Ming-Lung Yu; Raymond T Chung
Journal:  Expert Opin Drug Saf       Date:  2017-05-19       Impact factor: 4.250

3.  Dual chronic hepatitis B virus and hepatitis C virus infection.

Authors:  Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen
Journal:  Hepatol Int       Date:  2009-08-08       Impact factor: 6.047

4.  Clinical significance of isolated anti-hbc positivity in cases of chronic liver disease in new delhi, India.

Authors:  Manisha Jain; Anita Chakravarti; P Kar
Journal:  J Glob Infect Dis       Date:  2009-01

Review 5.  Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.

Authors:  Pankaj Puri; Anil C Anand; Vivek A Saraswat; Subrat K Acharya; Shiv K Sarin; Radha K Dhiman; Rakesh Aggarwal; Shivaram P Singh; Deepak Amarapurkar; Anil Arora; Mohinish Chhabra; Kamal Chetri; Gourdas Choudhuri; Vinod K Dixit; Ajay Duseja; Ajay K Jain; Dharmesh Kapoor; Premashis Kar; Abraham Koshy; Ashish Kumar; Kaushal Madan; Sri P Misra; Mohan V G Prasad; Aabha Nagral; Amarendra S Puri; R Jeyamani; Sanjiv Saigal; Samir Shah; Praveen K Sharma; Ajit Sood; Sandeep Thareja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2014-06-24

6.  Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B.

Authors:  YuFeng Lou; ManYi Wang; WeiLin Mao
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

7.  Hepatitis B and C Viruses, Their Coinfection and Correlations in Chronic Liver Disease Patients: A Tertiary Care Hospital Study.

Authors:  Udhayvir Singh Grewal; Geeta Walia; Rupinder Bakshi; Siddharth Chopra
Journal:  Int J Appl Basic Med Res       Date:  2018 Oct-Dec

Review 8.  Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV).

Authors:  Mariantonietta Pisaturo; Margherita Macera; Loredana Alessio; Federica Calò; Nicola Coppola
Journal:  Viruses       Date:  2019-09-13       Impact factor: 5.048
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.